Abstract 2120P
Background
Malnutrition is frequent, but underdiagnosed consequence of gastrectomy. Nutritional status is an important factor influencing optimal recovery after treatment. The aim of the present study was to assess the prevalence of micronutrient deficiencies post gastrectomies.
Methods
Between January 2022 and January 2023, 115 patients post gastrectomy had micronutrient screening including vitamin B12, vitamin D, folate, ferritin and albumin. Patients with any micronutrients deficiency were invited for a follow-up and rehabilitation (nutrient rich diet, supplements). Descriptive statistics and t-tests.
Results
Patients’ characteristics were as follow: 64.3% women and 35.6% men; median age 58 [30-81]; median follow-up period 19 months [2-24]; proportion of patients with deficiency in vitamin B12, vitamin D, folate, ferritin and albumin were 5.2%,40%,10.4%, 23.4% and 20.9%, respectively. We observed significant improvement in several indicators (vitamin B12 156→357mmol/l, vitamin D 24.6→69.4mmol/l, folate 2.7→9.6mmol/l, ferritin 16.4→92.2mmol/l, albumin 2.2→3.0mmol/l, p=0.01).
Conclusions
This study defined the prevalence of micronutrient deficiencies post gastrectomy. Appropriate nutritional intervention based on findings micronutrients deficiency led to improve quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2045P - Patient Reported Outcome Measures (PROMs) capturing therapy adherence of cancer patients: A systematic literature review
Presenter: Luise Richter
Session: Poster session 06
2046P - The importance of communicating bad news in medical education
Presenter: Georgios Goumas
Session: Poster session 06
2047P - Neutrop: A descriptive, observational study for G-CSF prescription in daily practice
Presenter: Florian Scotté
Session: Poster session 06
2048P - Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
Presenter: Lotte Hulskotte
Session: Poster session 06
2049P - Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting
Presenter: Gisele Moreira
Session: Poster session 06
2050P - Integrating ayurveda herbs with standard of care for management of cancer or cancer treatment related anorexia
Presenter: Yogesh Bendale
Session: Poster session 06
2051P - E-PRO within comprehensive companion program for patients undergoing systemic cancer treatment to reduce emergency visits and inpatient admission in a Peruvian institution
Presenter: Patricia Rioja Viera
Session: Poster session 06
2052P - Adverse events in FLOT chemotherapy for locally advanced gastric cancer: An observational study of pre- and post-operative toxicity profiles
Presenter: Camila Oliveira
Session: Poster session 06
2053P - Dehospitalization through outpatient drug release in clinical pharmacy as a strategic cost-minimization action in a public oncology hospital in the Eastern Amazon: A quantitative analysis
Presenter: Kalysta Borges
Session: Poster session 06
2054P - Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Presenter: Colin Vercueil
Session: Poster session 06